Lv1
14 积分 2023-08-02 加入
Characterization of stability, safety and immunogenicity of the mRNA lipid nanoparticle vaccine Iribovax® against COVID-19 in nonhuman primates
1天前
已完结
Nonclinical safety evaluation strategies for mRNA/LNPs platform agents: Evidence from comprehensive animal toxicity studies
1天前
已完结
Lipid Nanoparticle-Mediated Systemic RNA Delivery to the Spleen: Strategies, Applications, and Challenges
3个月前
已完结
皖公网安备34019202002308
